Table 1.
Positives IIF patients | Malignant neoplasm (n = 1,217) | No malignant disease (n = 13,934) | Relative risk | 95% CI |
---|---|---|---|---|
Speckled (n = 1,333) | 106 (8%) | 1,227 (92%) | RR = 1.2 | 0.9 to 1.6 |
Homogeneous & speckled (n = 673) | 34 (5%) | 639 (95%) | RR = 0.7 | 0.5 to 0.9 |
Homogeneous (n = 536) | 36 (7%) | 500 (93%) | RR = 0.8 | 0.6 to 1.1 |
Nucleolar (n = 240) | 25 (10%) | 215 (90%) | RR = 1.5 | 1.03 to 2.3 |
Centromere (n = 100) | 4 (4%) | 96 (96%) | RR = 0.5 | 0.2 to 1.4 |
Other (n = 21) | 0 (0%) | 14 (100%) | NA | NA |
Total (n = 2,903) | 205 | 2,698 |
NA, not applicable.